The percentage of CD4+CD25+Foxp3+ Tregs subset was increased in SCLC patients compared to that of healthy controls (6.11 [2.13–13.5] vs. 3.8 [2.74–8.30], p = 0.0083, Fig. 2g, h). Here, FOXP3 is linked to small cell lung carcinoma.